Results 61 to 70 of about 19,093 (232)

Adrenoleukodystrophy in a Nigerian boy: A case report and review of literature

open access: yesNigerian Journal of Paediatrics, 2021
Adrenoleukodystrophy (ALD) is a hereditary, X-linked metabolic disorder with autosomal recessive traits. It arises from mutation in ABCD1 gene on chromosome Xq28.
Akowundu Pauline Karachi   +3 more
doaj  

Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy

open access: yesNew England Journal of Medicine
BACKGROUND Gene therapy with elivaldogene autotemcel (eli-cel) consisting of autologous CD34+ cells transduced with lentiviral vector containing ABCD1 complementary DNA (Lenti-D) has shown efficacy in clinical studies for the treatment of cerebral ...
Christine N Duncan   +22 more
semanticscholar   +1 more source

Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies.

open access: yesBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021
X-linked adrenoleukodystrophy (X-ALD) is an inherited neurodegenerative disorder associated with mutations of the ABCD1 gene that encodes a peroxisomal transmembrane protein.
C. Ma   +9 more
semanticscholar   +1 more source

MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines

open access: yesJournal of Inherited Metabolic Disease, 2020
Among boys with X‐Linked adrenoleukodystrophy, a subset will develop childhood cerebral adrenoleukodystrophy (CCALD). CCALD is typically lethal without hematopoietic stem cell transplant before or soon after symptom onset. We sought to establish evidence‐
E. Mallack   +22 more
semanticscholar   +1 more source

Lipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy

open access: yesCommunications Medicine
X-linked adrenoleukodystrophy (ALD) is a neurometabolic disorder caused by pathogenic variants in ABCD1 resulting very long-chain fatty acids (VLCFA) accumulation in plasma and tissues.
Yorrick R. J. Jaspers   +15 more
semanticscholar   +1 more source

The Changing Face of Adrenoleukodystrophy.

open access: yesEndocrine reviews, 2020
Adrenoleukodystrophy (ALD) is a rare X-linked disorder of peroxisomal oxidation due to mutations in ABCD1. It is a progressive condition with a variable clinical spectrum that includes primary adrenal insufficiency, myelopathy, and cerebral ALD.
Jia Zhu   +5 more
semanticscholar   +1 more source

Visual Pigment Gene Changes in Adrenoleukodystrophy [PDF]

open access: yes, 2020
Purpose. The gene for X-linked adrenoleukodystrophy, a neurodegenerative disorder, is closely linked to the red/green color pigment genes on the distal X-chromosome Xq28 and one kindred is known to have a genetic change affecting both loci.
/ R   +5 more
core  

‐linked adrenoleukodystrophy among adult men with Addison's disease [PDF]

open access: yes, 2013
ObjectivesX-linked adrenoleukodystrophy is an important cause of Addison's disease in boys, but less is known about its contribution to Addison's disease in adult men.
Morten A. Horn   +13 more
core   +1 more source

Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy

open access: yesJournal of Neuroinflammation, 2011
Background Adrenoleukodystrophy (ALD) is an X-linked peroxisomal disorder characterized by the abnormal beta-oxidation of very long chain fatty acids (VLCFA).
Orchard Paul J   +8 more
doaj   +1 more source

The pathology of X-linked adrenoleukodystrophy: tissue specific changes as a clue to pathophysiology

open access: yesOrphanet Journal of Rare Diseases
Although the pathology of X-linked adrenoleukodystrophy (ALD) is well described, it represents the end-stage of neurodegeneration. It is still unclear what cell types are initially involved and what their role is in the disease process.
H. A. Yska, M. Engelen, Marianna Bugiani
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy